| Basics |
Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
|
| IPO Date: |
September 11, 2017 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$211.97M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.18 | 2.50%
|
| Avg Daily Range (30 D): |
$0.19 | 2.69%
|
| Avg Daily Range (90 D): |
$0.16 | 2.46%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.09M |
| Avg Daily Volume (30 D): |
.08M |
| Avg Daily Volume (90 D): |
.07M |
| Trade Size |
| Avg Trade Size (Sh.): |
131 |
| Avg Trade Size (Sh.) (30 D): |
85 |
| Avg Trade Size (Sh.) (90 D): |
100 |
| Institutional Trades |
| Total Inst.Trades: |
34 |
| Avg Inst. Trade: |
$2.95M |
| Avg Inst. Trade (30 D): |
$.63M |
| Avg Inst. Trade (90 D): |
$1.03M |
| Avg Inst. Trade Volume: |
.37M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.7M |
| Avg Closing Trade (30 D): |
$3.23M |
| Avg Closing Trade (90 D): |
$3.23M |
| Avg Closing Volume: |
817.09K |
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-.04
|
$-.08
|
$-.02
|
|
Diluted EPS
|
$-.04
|
$-.08
|
$-.02
|
|
Revenue
|
$ 8.75M
|
$ 7.93M
|
$ 47.54M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -1.17M
|
$ -1.99M
|
$ -.44M
|
|
Operating Income / Loss
|
$ -.81M
|
$ -.93M
|
$ 2.57M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ M
|
$ M
|
$ M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Sep 05, 2014:
1:3
|
|
Aug 30, 2011:
1:18
|
|
Aug 02, 2005:
1:5
|
|
|
|
